Long-Term Assets: The sum of all assets classified as non-current.
Pasithea Therapeutics Corp. (KTTA) had Long-Term Assets of $3.78M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.11M |
|
-- |
|
-- |
|
$10.26M |
|
$-10.26M |
|
$0.15M |
|
$-10.11M |
|
$-10.11M |
|
$-10.11M |
|
$-10.11M |
|
$-10.11M |
|
$-10.11M |
|
$-10.26M |
|
$-10.10M |
|
7.03M |
|
7.03M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$56.46M |
|
-- |
|
|
Long-Term Assets |
$3.78M |
$60.24M |
|
$4.97M |
|
-- |
|
$0.05M |
|
$5.02M |
|
$55.22M |
|
$51.44M |
|
$55.22M |
|
23.09M |
|
| Cash Flow Statement Financials | |
$-15.21M |
|
$0.01M |
|
$63.52M |
|
$6.92M |
|
$55.26M |
|
$48.34M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.31% |
|
-19.66% |
|
-16.78% |
|
-18.31% |
|
$2.39 |
|
$-2.16 |
|
$-2.16 |
|